Baicheng Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Baicheng Xia has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Aili Cui
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing China
4 shared publicationsFeng Zhang
Laboratory of Viral Diseases, Qingdao Municipal Center for Disease Control and Prevention, Qingdao Institute of Prevention Medicine Qingdao China
4 shared publicationsYan Zhang
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing China
4 shared publicationsChongyang Li
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing China
3 shared publicationsJing Xu
Virus Disease Prevention and Control Institute, Shaanxi Provincial Center for Disease Control and Prevention Xian China
3 shared publicationsNaiying Mao
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing China
3 shared publications
Latest Publications
- 29 May 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (6) , e70993
Genomic Analysis Reveals Dominance of Human Adenovirus Genotype B114 Among Circulating Strains Historically Identified as B3
Human adenovirus (HAdV)−114 (P7H3F3) is a newly identified recombinant genotype, while recent studies suggest that it likely represents a previously circulating HAdV‐3 strain. A total of 413 strains previously identified as HAdV‐3 from 20 Chinese provinces during 2000–2024, along with 125 GenBank‐derived HAdV‐3 strains (1988–2023), underwent genotype reconfirmation and genetic evolutionary analysis using the penton base, hexon, and fiber genes. Furthermore, 97 representative strains were selected for whole‐genome analysis to determine their genetic recombination patterns. Of the 538 analyzed strains, 537 were identified as HAdV‐114 using three genes, with only one 2010 U.S strain classified as HAdV‐3. Phylogenetic analysis revealed three HAdV‐114 clades (Clades 1–3): Clade 1 (1988–2019) displayed sporadic circulation, Clade 2 (2023–2024) appeared geographically restricted to three Chinese provinces, and Clade 3 (2000–2024) likely represented the globally dominant strain. Genetic evolutionary analyses indicated that, although HAdV‐114 originated from recombination between HAdV‐7 and HAdV‐3, its three Clades diverged from the parental trajectories, with Clades 1 and 3 sharing a common evolutionary origin and Clade 2 forming an independent terminal cluster. Genomic recombination analysis identified two recombination patterns across the three clades. All clades shared a 3′ terminal genomic region (nt 18,794–end) derived from HAdV‐3, whereas their 5′ ends comprised gene fragments recombined from unknown sources and epidemic HAdV‐7 strains, with varied breakpoints. HAdV‐114, historically identified as HAdV‐3, is the predominant genotype associated with HAdV‐related respiratory infections. Therefore, enhanced surveillance of recombinant HAdV strains is imperative for effective disease control.
- 29 May 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (6) , e70993
Genomic Analysis Reveals Dominance of Human Adenovirus Genotype B114 Among Circulating Strains Historically Identified as B3
Human adenovirus (HAdV)−114 (P7H3F3) is a newly identified recombinant genotype, while recent studies suggest that it likely represents a previously circulating HAdV‐3 strain. A total of 413 strains previously identified as HAdV‐3 from 20 Chinese provinces during 2000–2024, along with 125 GenBank‐derived HAdV‐3 strains (1988–2023), underwent genotype reconfirmation and genetic evolutionary analysis using the penton base, hexon, and fiber genes. Furthermore, 97 representative strains were selected for whole‐genome analysis to determine their genetic recombination patterns. Of the 538 analyzed strains, 537 were identified as HAdV‐114 using three genes, with only one 2010 U.S strain classified as HAdV‐3. Phylogenetic analysis revealed three HAdV‐114 clades (Clades 1–3): Clade 1 (1988–2019) displayed sporadic circulation, Clade 2 (2023–2024) appeared geographically restricted to three Chinese provinces, and Clade 3 (2000–2024) likely represented the globally dominant strain. Genetic evolutionary analyses indicated that, although HAdV‐114 originated from recombination between HAdV‐7 and HAdV‐3, its three Clades diverged from the parental trajectories, with Clades 1 and 3 sharing a common evolutionary origin and Clade 2 forming an independent terminal cluster. Genomic recombination analysis identified two recombination patterns across the three clades. All clades shared a 3′ terminal genomic region (nt 18,794–end) derived from HAdV‐3, whereas their 5′ ends comprised gene fragments recombined from unknown sources and epidemic HAdV‐7 strains, with varied breakpoints. HAdV‐114, historically identified as HAdV‐3, is the predominant genotype associated with HAdV‐related respiratory infections. Therefore, enhanced surveillance of recombinant HAdV strains is imperative for effective disease control.
- 9 October 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (10) , e70632
Evolutionary Dynamics of Human Parainfluenza Virus Type 1 Based on the Hemagglutinin‐Neuraminidase Gene
To elucidate the evolutionary dynamics of human parainfluenza virus type 1 (HPIV1), we obtained 78 Chinese HPIV1 hemagglutinin‐neuraminidase (HN) gene sequences between 2011 and 2017–2023 and generated two databases: global (482 sequences, 1956–2023) and Chinese HPIV1 (122 sequences, 2011–2023). Our results showed that global HPIV1 circulating since the 1990s could be classified into five genotypes (A, B, C, D, and E) using a genetic distance threshold of 0.02. Among these, genotypes B and C were predominantly prevalent worldwide, including in China, whereas genotype D showed distinct spatial clustering (mainly in China) and was believed to undergo relatively rapid transmission and evolution. We also confirmed the conserved nature of HPIV1 over the last six decades, with an overall evolutionary rate of 9.41 × 10 −4 substitutions/site/year. Additionally, genotype‐specific amino acid substitutions and potential N‐glycosylation sites in HN were identified. These findings provide insights into the genetic characteristics of HPIV1.
- 9 October 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (10) , e70632
Evolutionary Dynamics of Human Parainfluenza Virus Type 1 Based on the Hemagglutinin‐Neuraminidase Gene
To elucidate the evolutionary dynamics of human parainfluenza virus type 1 (HPIV1), we obtained 78 Chinese HPIV1 hemagglutinin‐neuraminidase (HN) gene sequences between 2011 and 2017–2023 and generated two databases: global (482 sequences, 1956–2023) and Chinese HPIV1 (122 sequences, 2011–2023). Our results showed that global HPIV1 circulating since the 1990s could be classified into five genotypes (A, B, C, D, and E) using a genetic distance threshold of 0.02. Among these, genotypes B and C were predominantly prevalent worldwide, including in China, whereas genotype D showed distinct spatial clustering (mainly in China) and was believed to undergo relatively rapid transmission and evolution. We also confirmed the conserved nature of HPIV1 over the last six decades, with an overall evolutionary rate of 9.41 × 10 −4 substitutions/site/year. Additionally, genotype‐specific amino acid substitutions and potential N‐glycosylation sites in HN were identified. These findings provide insights into the genetic characteristics of HPIV1.
- 19 April 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (4) , e29618
Genetic characterization of pediatric SARI‐associated human adenoviruses in eight Chinese provinces during 2017–2021
Human adenovirus (HAdV) is a significant viral pathogen causing severe acute respiratory infections (SARIs) in children. To improve the understanding of type distribution and viral genetic characterization of HAdV in severe cases, this study enrolled 3404 pediatric SARI cases from eight provinces of China spanning 2017–2021, resulting in the acquisition of 112 HAdV strains. HAdV‐type identification, based on three target genes (penton base, hexon, and fiber), confirmed the diversity of HAdV types in SARI cases. Twelve types were identified, including species B (HAdV‐3, 7, 55), species C (HAdV‐1, 2, 6, 89, 108, P89H5F5, Px1/Ps3H1F1, Px1/Ps3H5F5), and E (HAdV‐4). Among these, HAdV‐3 exhibited the highest detection rate (44.6%), followed by HAdV‐7 (19.6%), HAdV‐1 (12.5%), and HAdV‐108 (9.8%). All HAdV‐3, 7, 55, 4 in this study belonged to dominant lineages circulating worldwide, and the sequences of the three genes demonstrated significant conservation and stability. Concerning HAdV‐C, excluding the novel type Px1/Ps3H1F1 found in this study, the other seven types were detected both in China and abroad, with HAdV‐1 and HAdV‐108 considered the two main types of HAdV‐C prevalent in China. Two recombinant strains, including P89H5F5 and Px1/Ps3H1F1, could cause SARI as a single pathogen, warranting close monitoring and investigation for potential public health implications. In conclusion, 5 years of SARI surveillance in China provided crucial insights into HAdV‐associated respiratory infections among hospitalized pediatric patients.
- 19 April 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (4) , e29618
Genetic characterization of pediatric SARI‐associated human adenoviruses in eight Chinese provinces during 2017–2021
Human adenovirus (HAdV) is a significant viral pathogen causing severe acute respiratory infections (SARIs) in children. To improve the understanding of type distribution and viral genetic characterization of HAdV in severe cases, this study enrolled 3404 pediatric SARI cases from eight provinces of China spanning 2017–2021, resulting in the acquisition of 112 HAdV strains. HAdV‐type identification, based on three target genes (penton base, hexon, and fiber), confirmed the diversity of HAdV types in SARI cases. Twelve types were identified, including species B (HAdV‐3, 7, 55), species C (HAdV‐1, 2, 6, 89, 108, P89H5F5, Px1/Ps3H1F1, Px1/Ps3H5F5), and E (HAdV‐4). Among these, HAdV‐3 exhibited the highest detection rate (44.6%), followed by HAdV‐7 (19.6%), HAdV‐1 (12.5%), and HAdV‐108 (9.8%). All HAdV‐3, 7, 55, 4 in this study belonged to dominant lineages circulating worldwide, and the sequences of the three genes demonstrated significant conservation and stability. Concerning HAdV‐C, excluding the novel type Px1/Ps3H1F1 found in this study, the other seven types were detected both in China and abroad, with HAdV‐1 and HAdV‐108 considered the two main types of HAdV‐C prevalent in China. Two recombinant strains, including P89H5F5 and Px1/Ps3H1F1, could cause SARI as a single pathogen, warranting close monitoring and investigation for potential public health implications. In conclusion, 5 years of SARI surveillance in China provided crucial insights into HAdV‐associated respiratory infections among hospitalized pediatric patients.
- 9 April 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (4) , e29582
Prevalence and genetic diversity of human rhinovirus among patients with acute respiratory infections in China, 2012−2021
To understand the prevalence of rhinovirus (RV) among acute respiratory infection (ARI) patients, 10‐year ARI surveillance in multiple provinces of China were conducted during 2012−2021. Of 15 645 ARI patients, 1180 (7.54%) were confirmed to have RV infection and 820 (69.49%) were children under 5 years of age. RV typing was performed on the 527 VP1 gene sequences, and species A, B, and C accounted for 73.24%, 4.93%, and 21.82%, respectively. Although no significant difference in the proportions of age groups or disease severity was found between RV species, RV‐C was more frequently detected in children under 5 years of age, RV‐A was more frequently detected in elderly individuals (≥60), and the proportions of pneumonia in RV‐A and RV‐C patients were higher than those in RV‐B patients. The epidemic peak of RV‐A was earlier than that of RV‐C. A total of 57 types of RV‐A, 13 types of RV‐B, and 35 types of RV‐C were identified in RV‐infected patients, and two uncertain RV types were also detected. The findings showed a few differences in epidemiological and clinical features between RV species in ARI patients, and RV‐A and RV‐C were more prevalent than RV‐B.
- 9 April 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (4) , e29582
Prevalence and genetic diversity of human rhinovirus among patients with acute respiratory infections in China, 2012−2021
To understand the prevalence of rhinovirus (RV) among acute respiratory infection (ARI) patients, 10‐year ARI surveillance in multiple provinces of China were conducted during 2012−2021. Of 15 645 ARI patients, 1180 (7.54%) were confirmed to have RV infection and 820 (69.49%) were children under 5 years of age. RV typing was performed on the 527 VP1 gene sequences, and species A, B, and C accounted for 73.24%, 4.93%, and 21.82%, respectively. Although no significant difference in the proportions of age groups or disease severity was found between RV species, RV‐C was more frequently detected in children under 5 years of age, RV‐A was more frequently detected in elderly individuals (≥60), and the proportions of pneumonia in RV‐A and RV‐C patients were higher than those in RV‐B patients. The epidemic peak of RV‐A was earlier than that of RV‐C. A total of 57 types of RV‐A, 13 types of RV‐B, and 35 types of RV‐C were identified in RV‐infected patients, and two uncertain RV types were also detected. The findings showed a few differences in epidemiological and clinical features between RV species in ARI patients, and RV‐A and RV‐C were more prevalent than RV‐B.